Animal & Veterinary
FDA Holding Workshop on Minor Use and Minor Species Drugs
June 22, 2004
FDA is holding a public workshop entitled “International Workshop on Minor Use and Minor Species (MUMS): A Global Perspective.” The meeting will be held on October 7, 2004 , from 8:30 a.m. to 5:45 p.m. and on October 8, 2004 from 8:30 a.m. to 12:15 p.m. The workshop will be held at the DoubleTree Hotel, Plaza Room III, 1750 Rockville Pike, Rockville , MD 20852 .
The workshop is a result of a partnership between FDA’s Center for Veterinary Medicine (CVM) and the U.S. Department of Agriculture’s (USDA’s) minor use animal drug program, the National Research Support Project #7 (NRSP-7). The purpose of the workshop is to assemble international expertise to discuss the global pursuit of drug approvals for MUMS. Areas to be discussed include data requirements for MUMS drug approvals, the classification of minor species, and husbandry practices in various regions of the world. We anticipate that the workshop will include methods and strategies to improve cooperation and coordination of national and regional programs to maximize MUMS approvals internationally.
Registration forms for the workshop are available from the CVM Home Page and should be completed on-line. If a paper copy is needed, contact Anna Roy, Center for Veterinary Medicine, 7519 Standish Place, Rockville, MD 20855 at 301-827-2957, Fax 301-827-4572, or e-mail email@example.com by October 6, 2004 . There is no registration fee for the workshop. Limited space is available, so early registration is encouraged. If you require special accommodations due to a disability, please contact Anna Roy, at least 7 days in advance of the meeting.
When it is available, the draft agenda and any updated information about the workshop will be included on the CVM Home Page and the NRSP-7 web site.
Additional information about the workshop is included in the June 22, 2004 , Federal Register . Questions about the workshop may be directed to Dr. Meg Oeller, CVM, 301-827-3067 or firstname.lastname@example.org.